VNPEPS
Encyclopedia · Nov 2, 2026

Tirzepatide: research, regimens, price

Everything published about Tirzepatide: mechanism, research areas, results, regimens, risks, comparisons — plus the dated Vietnam price and ordering rules.

Order from VietPeptideAll prices

FormatPrice (index Nov 2, 2026)Delivery
20 mgfrom 1 500 000 ₫Da Nang ~30 min · Vietnam 1–2 days

Compound dossier

What it is

Tirzepatide brings together two appetite and metabolic pathways: GIP and GLP-1. It helps explain why this peptide has become one of the most discussed names in weight-management research.

Status and action

A dual GIP/GLP-1 receptor agonist. Licensed formulations are used for type 2 diabetes and chronic weight management in eligible populations.

In short

A dual-action peptide with substantial clinical weight-management results and a clear connection to appetite and glucose regulation.

Research results

In a 72-week weight-management trial, adults without diabetes lost an average of 15.0%, 19.5% and 20.9% at 72 weeks in the 5, 10 and 15 mg groups, versus 3.1% with placebo. All groups received lifestyle support.

Research regimens

Licensed once-weekly subcutaneous schedule: Weeks 1–4: 2.5 mg weekly From week 5: 5 mg weekly Further increases: 2.5 mg at a time, after at least four weeks at the current dose. Weight-management maintenance doses: 5, 10 or 15 mg weekly; maximum 15 mg. Treatment is generally long term. A major weight-management trial followed participants for 72 weeks.

Risks and limits

Nausea, diarrhoea, vomiting and constipation are common. Important precautions include pancreatitis, gallbladder disease, pregnancy, medullary thyroid cancer/MEN2 and hypoglycaemia with insulin or sulfonylureas. Oral contraceptives need an additional or non-oral method for four weeks after starting and each dose increase.

Comparison

Tirzepatide activates GIP and GLP-1; semaglutide activates GLP-1. The additional GIP pathway is tirzepatide’s defining feature.

FAQ

How much does Tirzepatide cost in Vietnam?

from 1 500 000 ₫ for 20 mg (index Nov 2, 2026); final total confirmed in writing before payment.

Is this a medicine?

No: research material, not a prescription drug; no medical claims.

Transparency: research data from published sources; regimens are research context, not medical advice. Price — public VietPeptide index. Full RU dossier: Tirzepatide (RU)